- Home
- BBIO vs RYAN Comparison
BBIO vs RYAN Comparison
Compare BBIO & RYAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- RYAN
- Stock Information
- Founded
- BBIO 2015
- RYAN 2010
- Country
- BBIO United States
- RYAN United States
- Employees
- BBIO N/A
- RYAN N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- RYAN Specialty Insurers
- Sector
- BBIO Health Care
- RYAN Finance
- Exchange
- BBIO Nasdaq
- RYAN Nasdaq
- Market Cap
- BBIO 8.0B
- RYAN 8.8B
- IPO Year
- BBIO 2019
- RYAN 2021
- Fundamental
- Price
- BBIO $42.78
- RYAN $67.77
- Analyst Decision
- BBIO Strong Buy
- RYAN Buy
- Analyst Count
- BBIO 14
- RYAN 13
- Target Price
- BBIO $58.85
- RYAN $74.36
- AVG Volume (30 Days)
- BBIO 3.3M
- RYAN 890.1K
- Earning Date
- BBIO 07-31-2025
- RYAN 07-31-2025
- Dividend Yield
- BBIO N/A
- RYAN 0.71%
- EPS Growth
- BBIO N/A
- RYAN N/A
- EPS
- BBIO N/A
- RYAN 0.27
- Revenue
- BBIO $127,415,000.00
- RYAN $2,593,912,000.00
- Revenue This Year
- BBIO $102.05
- RYAN $27.75
- Revenue Next Year
- BBIO $54.69
- RYAN $15.43
- P/E Ratio
- BBIO N/A
- RYAN $250.74
- Revenue Growth
- BBIO N/A
- RYAN 22.53
- 52 Week Low
- BBIO $21.72
- RYAN $55.67
- 52 Week High
- BBIO $45.48
- RYAN $77.16
- Technical
- Relative Strength Index (RSI)
- BBIO 62.54
- RYAN 49.47
- Support Level
- BBIO $39.65
- RYAN $66.54
- Resistance Level
- BBIO $45.48
- RYAN $69.10
- Average True Range (ATR)
- BBIO 1.56
- RYAN 1.47
- MACD
- BBIO 0.15
- RYAN 0.17
- Stochastic Oscillator
- BBIO 60.90
- RYAN 69.77
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About RYAN Ryan Specialty Holdings Inc.
Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.